Monopar Therapeutics - COM (MNPR)

Historical Portfolio Holders from Q4 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
418K
Holdings value Q2 2024
$310K
Value change Q2 2024
+$19.9K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
12
Number of buys Q2 2024
0
Number of sells Q2 2024
-3
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 0 $0 -$73.2K 0
2024 Q2 418K $310K +$19.9K $0.73 12
2024 Q1 395K $268K +$109K $0.68 15
2023 Q4 271K $91.7K -$55K $0.34 13
2023 Q3 301K $182K +$66.5K $0.62 13
2023 Q2 192K $165K -$72.9K $0.86 8
2023 Q1 232K $323K +$45.3K $1.39 11
2022 Q4 199K $471K +$9.48K $2.37 10
2022 Q3 199K $314K -$17.6K $1.51 8
2022 Q2 207K $471K +$9.87K $2.25 9
2022 Q1 204K $520K -$1.22K $2.55 10
2021 Q4 204K $655K +$17.7K $3.22 10
2021 Q3 198K $963K +$53K $4.87 7
2021 Q2 187K $1.1M -$63K $5.89 8
2021 Q1 195K $1.21M +$773K $6.20 12
2020 Q4 69.9K $429K -$34.1K $6.19 6
2020 Q3 75.4K $403K +$99.6K $5.32 4
2020 Q2 56.8K $424K +$292K $7.46 4
2020 Q1 17.9K $130K -$208K $7.16 4
2019 Q4 26.4K $439K +$439K $16.59 4